ABOUT US
INVESTORS
Pitango Venture Capital
Pitango Venture Capital is one of Israel’s leading venture capital firms. Now in its thirteenth year, Pitango has helped cultivate more than 100 companies in seed, early and expansion stage in a diversified range of technology sectors. Pitango manages funds in excess of $1 billion in committed capital from well-established international investors from the firm’s offices in Israel and the Silicon Valley. Pitango, through its team of investment professionals, has earned a solid reputation for nurturing innovation and working hand-in-hand with entrepreneurs in building sustainable and successful businesses. www.pitango.com
www.pitango.com
HBM BioVentures
HBM BioVentures is a leading holding company in the human medicine, biotech and medical technology industries. It enables investors to tap in to a broadly diversified portfolio of private and primarily small-cap public companies with high value creation potential in an investment segment that is difficult to access. HBM BioVentures is recognized as a complement to traditional pharmaceutical and biotech investments. HBM BioVentures is an active investor which finances, supports and shapes portfolio companies as a key partner. HBM’s team of specialists has the therapeutic know-how, operational experience and wide-ranging expertise in research and development, management and finance to provide a sound basis for above-average returns. With net assets of over CHF 1 billion, HBM BioVentures is a market leader in its sector. HBM BioVentures Ltd is domiciled in Baar, Switzerland, and has a broad shareholder base. HBM BioVentures shares are traded over the counter.
www.hbmbioventures.com
Vitalife Life Sciences
Vitalife Life Sciences Fund was established by a team of medical and financial investment experts who saw the profitable global trends in the life sciences field and who could appreciate the revolutionary nature of medical innovations of numerous early stage start-ups. Vitalife works together with its portfolio companies as a team to build successful life science companies and in parallel to earn the best return for its investors. Vitalife is represented globally through its sponsors and strategic investors. Vitalife Life Sciences Fund investors include fund sponsor Discount Capital Markets & Investments, SCP Private Equity Partners, L.P., Boston Scientific Corp and HarbourVest. www.vitalife.com
www.vitalifevc.com
Eucalyptus Ventures
Eucalyptus Ventures, Tamir Fishman & Company’s first fund, is a $55-million fund raised in 1998. It became fully invested in the final quarter of 1999. Eucalyptus Ventures invested in Israeli and Israeli-related growth companies, focusing on the high technology and the healthcare sectors. The Fund had focused on early stage companies with selected opportunities in later stage companies. From January 29, 2000 Pitango Venture Capital Fund directors and Eucalyptus Fund managing directors merged their management staffs in a new management corporation, Pitango Venture Capital.
www.tamirfishman.com; www.pitango.com
Biomedical Investments
Biomedical Investments engages in investment and management of life-sciences and biotech companies. The company's policy is to invest in early-stage start-up projects with substantial commercial potential. The company is currently focusing on several promising companies, and has already reached impressive results in past investments.
BMI is headed by Mr. Ruben Krupik and Mr. Ofer Gonen.
Shrem, Fudim, Kelner & Company
Shrem, Fudim, Kelner & Company (SFK) has been Israel's premier investment house for over 15 years, and provides a wide array of financial services to clients in Israel and abroad, including multinational corporations, governmental agencies and private investors. With more than US $2.5 billion in assets under management, SFK has broad international experience and investments, and highly-diversified activity in:
· Investment Banking
· Underwriting and Brokerage
· Venture Capital
· Asset Management
· Direct investments in technology, industry & real estate.
www.sfk.co.il
|
 |
|
|
